Kelyniam Global Announces Q2 2025 Financial Results
CANTON, Conn., Aug. 11, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the hal...
What is the insider trading activity or institutional ownership changes following the earnings release?
Did the company address any macroeconomic or supply chain risks that might impact its operations moving forward?
What is the status of the company's pipeline and any upcoming FDA submissions that could affect future earnings?
26 days ago